Mark W. Duncan, Ph.D.

Education and Experience

Current Appointments

• At the University of Colorado Health Sciences Center: Director, Biochemical Mass Spectrometry Facility Professor, Department of Pharmaceutical Sciences Professor, Department of Biochemistry and Molecular Genetics Director, Protein Microchemistry Core, University of Colorado Cancer Center Co-Director, Pharmacology Core, University of Colorado Cancer Center

• Honorary Visiting Professor, School of Physiology and Pharmacology, University of New South Wales, Sydney, Australia

Education

• Chartered Chemist and Fellow, Royal Australian Chemical Institute 1997

• Fogerty Visiting Fellow, Clinical Neurosciences Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health and Section on Analytical Biochemistry, Laboratory of Clinical Sciences, National Institute of Mental Health, Bethesda, Maryland, USA 1987-1990

• Postdoctoral Scholar, Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, Australia1986-1987

• National Health and Medical Research Council of Australia (NHMRC) Biomedical Postgraduate Scholar, University of New South Wales, Sydney, Australia1984-1987

• University of New South Wales, Sydney, Australia, B.Sc. (honors) 1979

• Director, Biomedical Mass Spectrometry Unit and Associate Professor, Faculty of Medicine, University of New South Wales, Sydney, Australia 1994-1999

• Director, Biomedical Mass Spectrometry Unit and Senior Lecturer, Faculty of Medicine, University of New South Wales, Sydney, Australia 1990-1993

• Visiting Associate, Clinical Neurosciences Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USAMarch-July 1990

• Research Officer, Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, Australia1980-1983